SUMMARY Two hundred and thirty seven semen samples from 10 institutes for artifical insemination by donor (AID) in Belgium and the Netherlands were tested for the presence of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum, herpes simplex virus, and cytomegalovirus. The incidence of these micro-organisms in the semen samples was 0%, 6.3%, 4.6%, 35.9%, 0%, and 0.4% respectively, and 47% of all samples were infected with one or more of the micro-organisms. As the ejaculates from which the samples had been taken had already been, or would be, used for AID, the exclusion of microbiological contamination with sexually communicable micro-organisms before insemination is indicated. Two hundred and thirty seven semen samples frozen at -1 96°C, from ten AID institutes in the Netherlands and Belgium were supplied in 0 25 ml or 0 5 ml straws. The semen had been given voluntarily by donors, who received a small sum for expenses. The samples were all diluted 2:1 or 1:1 with a cryoprotective liquid containing glycerol and sometimes also egg yolk or bovine serum albumin. Fifty samples contained ampicillin 380 mg/l and 36 contained kanamycin 5 mg/l. Forty samples came from an institution that used only fresh semen. The semen was diluted 1:1 with Eagle's modified minimum essential medium (EMEM) with 15% fetal calf serum, and was frozen to -196°C. Volumes of 120-200 ,l were diluted with 2 ml of EMEM for culture for Ngonorhoeae, C trachomatis, HSV, and CMV. Volumes of 60-200 ,l were suspended in 2 ml of U-9 medium' for culture for M hominis and U urealyticum.
SUMMARY Two hundred and thirty seven semen samples from 10 institutes for artifical insemination by donor (AID) in Belgium and the Netherlands were tested for the presence of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum, herpes simplex virus, and cytomegalovirus. The incidence of these micro-organisms in the semen samples was 0%, 6.3%, 4.6%, 35.9%, 0%, and 0.4% respectively, and 47% of all samples were infected with one or more of the micro-organisms. As the ejaculates from which the samples had been taken had already been, or would be, used for AID, the exclusion of microbiological contamination with sexually communicable micro-organisms before insemination is indicated. Materials (HIV) . The occurrence of infections with HIV through AID has, been described, however,'4 and serological examination of donors for both of these viruses is therefore indicated. It is not known whether the contaminated semen samples have caused infections in the recipients, nor is it clear whether the presence ofthe micro-organisms is of pathogenic importance. That would be assessed by investigating the number and serotype of the microorganism in question and the condition of the recipients' defence mechanisms. The importance of C trachomatis as a pathogenic agent in urethritis, cervicitis, salpingitis, neonatal conjunctivitis, and pneumonitis, however, has been well documented.'5 M hominis is associated with salpingitis, pyelonephritis, and postpartum fever, and U urealyticum can be associated with chorioamnionitis and possibly low birth weight.'6 One of the causes of the "TORCHES" syndrome in neonates is congenital infection with CMV.
The results of this screening therefore point to the need to examine both the donor and the semen before insemination to avoid contamination with pathogenic micro-organisms. This implies that only frozen semen samples should be used for AID purposes.
